Carocari Gift to Support Dr. Schwartz’s Ovarian Cancer Research
Deborah Carocari was only 36 when she was diagnosed with a rare form of advanced but low-grade ovarian cancer. At that time she received a prognosis of several months to a year from her physician, Peter Schwartz, MD, now the John Slade Ely Professor of Obstetrics, Gynecology, and Reproductive Sciences and Vice Chair, Gynecology. Debbie went on to defy those odds and battle the cancer for the next two decades. Although she ultimately succumbed to the disease, a generous gift from her estate is now making possible further ovarian cancer research by Dr. Schwartz.
Taylor Receives the “Distinguished Scientist Award” from Society for Reproductive Investigation for 2020
The 2020 Society for Reproductive Investigation “Distinguished Scientist Award” is given to Hugh S. Taylor, MD, chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale.
Innovations and Discoveries on the Horizon
On the evening of November 20, Dr. Hugh Taylor welcomed just over 20 guests to an intimate event at the Boyer Center, focusing on the department’s advances for women in gynecological cancer research and infertility. It was an inspiring opportunity for all the guests to gain a more nuanced understanding of the many contributions the Department has made—and is poised to continue make—in these critical aspects of women’s health.
Doctors working on better HPV vaccination coverage for pre-teens and teens
The vaccine for Human Papilloma Virus, according to recent studies, is working better than expected, even though vaccination rates in both Connecticut and the country are stagnating well below the target rate. To increase those rates, health experts are recommending doctors urge parents to get the vaccine for their pre-teens and teenagers as part of a back-to-school checkup.
Dr. Vikki Abrahams receives the 2019 American Society for Reproductive Immunology Award
Previously known as the Blackwell Munksgaard Award, the American Journal of Reproductive Immunology Award is presented annually to a senior investigator who has made outstanding contributions to the area of reproductive immunology. Contributions can be in the area of clinical or basic research.
SRC Midwife awarded American College of Nurse Midwives "Distinguished Service Award"
Richard Jennings, Certified Nurse Midwife at the YNHH Saint Raphael's Campus, received the Distinguished Service Award by the American College of Nurse Midwives at the annual meeting held in May, 2019. This Spring, Richard celebrated his 40th year of service as a nurse midwife.
New Stem-cell Cultivation Procedure Boosts Hope for Cures
When the Taylor lab in Yale’s Division of Reproductive Sciences extracted stem cells from human endometrial tissue—more commonly known as the uterine lining—the researchers were proud of their accomplishment. They didn’t think the find was extraordinary, and they certainly didn’t imagine that it might lead to treatments for a neurodegenerative condition. They were wrong—and happily so.
Yale OBGYN Research Highlighted in ASCO's 14th Annual Report on Progress Against Cancer
Advance of the Year: Progress in Treating Rare Cancers This year, ASCO names Progress in Treating Rare Cancers as the Advance of the Year. In the United States, rare cancers account for approximately 20% of all cancers diagnosed each year, and incidence rates vary worldwide. Progress has historically lagged behind the achievements made in more common cancers; however, five major studies this past year offer significant steps forward, making this a notable year for advances in rare cancers. Research from the Yale School of Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences was selected as #4: Trastuzumab effective for a rare form of endometrial cancer.
Hugh Taylor named president of American Society for Reproductive Medicine
Hugh Taylor, M.D., will be the next president of the American Society for Reproductive Medicine (ASRM), the largest American clinical organization for reproductive medicine specialists. His presidency was formally announced on Oct. 10 at the annual meeting of ASRM in Denver, Colorado.
Lots of Successful Women Are Freezing Their Eggs. But It May Not Be About Their Careers. (Featuring Dr. Patrizio & Dr. Inhorn)
“Freeze Your Eggs, Free Your Career,” announced the headline of a Bloomberg Businessweek cover story in 2014. It was the year that Facebook and then Apple began offering egg freezing as a benefit to employees. Hundreds of think pieces followed, debating the costs and benefits of “postponing procreation” in the name of professional advancement. In the years since, many more women across the world have frozen their eggs. Many are highly educated. But the decision may have very little to do with work, at least according to a new study. In interviews with 150 American and Israeli women who had undergone one cycle, career planning came up as the primary factor exactly two times.
Radiolab Episode: "Fronads" (Featuring Dr. Kutluk Oktay)
At 28 years old, Annie Dauer was living a full life. She had a job she loved as a highschool PE teacher, a big family who lived nearby, and a serious boyfriend. Then, cancer struck. Annie would come to find out she had Stage 4 non-Hodgkin's lymphoma. It was so aggressive, there was a real chance she might die. Her oncologists wanted her to start treatment immediately. Like, end-of-the-week immediately. But before Annie started treatment, she walked out of the doctor’s office and crossed the street to see a fertility doctor doing an experimental procedure that sounded like science fiction: ovary freezing.
Radiolab Episode: "The Primordial Journey" (Featuring Dr. Kutluk Oktay)
At two weeks old, the human embryo has only just begun its months-long journey to become a baby. The embryo is tiny, still invisible to the naked eye. But inside it, an epic struggle plays out, as a nomadic band of cells marches toward a mysterious destiny, with the future of humanity resting on their microscopic shoulders.